CHARLES SCHWAB INVESTMENT MANAGEMENT INC 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 5:23 pm Sale | 2024-09-30 | 13G | Emergent BioSolutions Inc. EBS | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,224,727 4.200% | -649,257 (-22.59%) | Filing |
| 2024-02-09 6:19 pm Purchase | 2023-12-31 | 13G | Emergent BioSolutions Inc. EBS | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,873,984 5.540% | 2,873,984 (New Position) | Filing |